Atossa Therapeutics (ATOS) Accumulated Expenses (2011 - 2026)
Atossa Therapeutics' Accumulated Expenses came in at $1.38 million for Q2 2026, down 37.3% from $2.2 million a year earlier and down 50.8% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics' Accumulated Expenses was $1.31 million, up 42.2% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 69.7% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $919,000 in FY2024 (-5.5%), $973,000 in FY2023 (-8.1%), $1.06 million in FY2022 (+419.1%) and $204,000 in FY2021 (+119.4%).
- The five-year range for quarterly Accumulated Expenses is $75,695 (Q3 2021) to $2.81 million (Q1 2026).
- Year-over-year, Accumulated Expenses increased in six of the last eight quarters, with growth averaging 16.8%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2023 (growth of 977.8%), and the weakest in Q2 2026 (a decline of 37.3%).
- Business Quant data shows ATOS's Accumulated Expenses at $2.81 million (Q1 2026), $1.31 million (Q4 2025) and $1.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Atossa Therapeutics | 21.38 Mn | -98.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.30 Mn |
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 2.81 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 919,000.00 |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 973,000.00 |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 803,000.00 |
| Mar 31, 2023 | 613,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 117,000.00 |
| Jun 30, 2022 | 834,000.00 |
| Mar 31, 2022 | 120,000.00 |
| Dec 31, 2021 | 204,000.00 |
API Access
Atossa Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();